• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Severe Pulmonary Hypertension: An Important Sequel After Severe Post-Acute COVID-19 Pneumonia.

作者信息

Cueto-Robledo Guillermo, Porres-Aguilar Mateo, Puebla-Aldama David, Barragán-Martínez María Del Pilar, Jurado-Hernández Merly Y, García-César Marisol, Rojas María B Torres, García-Treminio Carlos, Roldan-Valadez Ernesto

机构信息

Department of Cardiopulmonary Emergencies and Pulmonary Vascular Disorders Clinic; General Hospital of Mexico "Dr. Eduardo Liceaga"; Mexico City; Mexico; National Autonomous University of Mexico (UNAM); Mexico City, Mexico.

Department of Medicine; Division of Hospital and Adult Thrombosis Medicine; Texas Tech University Health Sciences Center; El Paso, TX.

出版信息

Curr Probl Cardiol. 2022 Mar;47(3):101004. doi: 10.1016/j.cpcardiol.2021.101004. Epub 2021 Sep 30.

DOI:10.1016/j.cpcardiol.2021.101004
PMID:34601005
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8482545/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68f9/8482545/59821e166eef/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68f9/8482545/b71afd741f16/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68f9/8482545/59821e166eef/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68f9/8482545/b71afd741f16/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68f9/8482545/59821e166eef/gr2_lrg.jpg

相似文献

1
Severe Pulmonary Hypertension: An Important Sequel After Severe Post-Acute COVID-19 Pneumonia.重度肺动脉高压：重症急性 COVID-19 肺炎后的一个重要后遗症。
Curr Probl Cardiol. 2022 Mar;47(3):101004. doi: 10.1016/j.cpcardiol.2021.101004. Epub 2021 Sep 30.
2
Pulmonary Hypertensive Changes Secondary to COVID-19 Pneumonia in a Chronically SARS-CoV-2-Infected Bilateral Lung Explant.慢性 SARS-CoV-2 感染双侧肺移植肺中 COVID-19 肺炎继发肺动脉高压改变。
Int J Surg Pathol. 2022 Jun;30(4):443-447. doi: 10.1177/10668969211064208. Epub 2021 Dec 13.
3
Chronic Thromboembolic Pulmonary Hypertension (CTEPH): A Review of Another Sequel of Severe Post-Covid-19 Pneumonia.慢性血栓栓塞性肺动脉高压（CTEPH）：严重新冠后肺炎的又一后果。
Curr Probl Cardiol. 2023 Aug;48(8):101187. doi: 10.1016/j.cpcardiol.2022.101187. Epub 2022 Mar 25.
4
Inhaled Nitric Oxide in Acute Severe Pulmonary Hypertension and Severe Acute Respiratory Distress Syndrome Secondary to COVID-19 Pneumonia: A Case Report.吸入一氧化氮治疗 COVID-19 肺炎所致急性重度肺动脉高压和重度急性呼吸窘迫综合征：病例报告。
Am J Case Rep. 2022 Oct 25;23:e937147. doi: 10.12659/AJCR.937147.
5
Electrocardiographic signs of acute right ventricular hypertrophy in patients with COVID-19 pneumonia: A clinical case series.新型冠状病毒肺炎患者急性右心室肥厚的心电图表现：临床病例系列
J Electrocardiol. 2020 Sep-Oct;62:100-102. doi: 10.1016/j.jelectrocard.2020.07.007. Epub 2020 Jul 21.
6
Acute pulmonary hypertension and short-term outcomes in severe Covid-19 patients needing intensive care.急性肺动脉高压与重症 COVID-19 患者需接受重症监护的短期结局。
Acta Anaesthesiol Scand. 2021 Jul;65(6):761-769. doi: 10.1111/aas.13819. Epub 2021 Mar 27.
7
[“Dum spiro spero”: clinicopathologic characteristics of SARS-CoV-2 infection].["一息尚存，希望不灭”：新型冠状病毒肺炎的临床病理特征]
Orv Hetil. 2021 Nov 7;162(45):1791-1802. doi: 10.1556/650.2021.32387.
8
Radiologic evolution of pulmonary arterial thrombosis associated with SARS-CoV-2 pneumonia.与新型冠状病毒肺炎相关的肺动脉血栓形成的影像学演变
Vasa. 2022 Jul;51(4):263-264. doi: 10.1024/0301-1526/a001015.
9
Chronic thromboembolic pulmonary hypertension secondary to Behçet's disease: an extremely rare pediatric case.继发于贝赫切特病的慢性血栓栓塞性肺动脉高压：一例极其罕见的儿科病例。
Cardiol Young. 2022 Feb;32(2):315-319. doi: 10.1017/S1047951121002730. Epub 2021 Jul 23.
10
Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.中国武汉严重肺炎患者的临床特征。
Respiration. 2020;99(8):649-657. doi: 10.1159/000507940. Epub 2020 Aug 25.

引用本文的文献

1
Systolic Pulmonary Artery Pressure as Long-Term Mortality Predictor in Elderly Critically Ill with Severe COVID-19 Pneumonia.收缩期肺动脉压作为老年重症新型冠状病毒肺炎患者长期死亡率的预测指标
Viruses. 2025 Feb 11;17(2):244. doi: 10.3390/v17020244.
2
An ABC approach to cardiothoracic complications and sequelae of COVID-19: a tertiary centre experience.一种针对 COVID-19 心胸部并发症和后遗症的 ABC 方法：一家三级中心的经验。
Clin Med (Lond). 2023 Nov;23(6):606-610. doi: 10.7861/clinmed.2023-0205.
3
Body composition and cardiorespiratory fitness of overweight COVID-19 survivors in different severity degrees: a cohort study.

本文引用的文献

1
At a crossroads: coronavirus disease 2019 recovery and the risk of pulmonary vascular disease.处于十字路口：2019 冠状病毒病康复与肺血管疾病风险。
Curr Opin Pulm Med. 2021 Sep 1;27(5):342-349. doi: 10.1097/MCP.0000000000000792.
2
COVID-19 patients may become predisposed to pulmonary arterial hypertension.COVID-19 患者可能易患肺动脉高压。
Med Hypotheses. 2021 Feb;147:110483. doi: 10.1016/j.mehy.2021.110483. Epub 2021 Jan 6.
3
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease.特发性肺纤维化相关肺动脉高压患者应用吸入曲前列尼尔治疗
超重 COVID-19 幸存者不同严重程度的身体成分和心肺功能适应性：一项队列研究。
Sci Rep. 2023 Oct 17;13(1):17615. doi: 10.1038/s41598-023-44738-8.
4
Role of Endothelium in Cardiovascular Sequelae of Long COVID.内皮细胞在新冠长期后遗症心血管并发症中的作用
Biomedicines. 2023 Aug 9;11(8):2239. doi: 10.3390/biomedicines11082239.
5
Hematological alterations associated with long COVID-19.与新冠长期症状相关的血液学改变。
Front Physiol. 2023 Jul 24;14:1203472. doi: 10.3389/fphys.2023.1203472. eCollection 2023.
6
Beyond Acute COVID-19: A Review of Long-term Cardiovascular Outcomes.超越急性 COVID-19：长期心血管结局综述。
Can J Cardiol. 2023 Jun;39(6):726-740. doi: 10.1016/j.cjca.2023.01.031. Epub 2023 Feb 6.
7
From acute SARS-CoV-2 infection to pulmonary hypertension.从新型冠状病毒2型（SARS-CoV-2）急性感染到肺动脉高压
Front Physiol. 2022 Dec 19;13:1023758. doi: 10.3389/fphys.2022.1023758. eCollection 2022.
8
Cardiopulmonary disease as sequelae of long-term COVID-19: Current perspectives and challenges.长期新冠后遗症中的心肺疾病：当前观点与挑战
Front Med (Lausanne). 2022 Nov 30;9:1041236. doi: 10.3389/fmed.2022.1041236. eCollection 2022.
9
Clinical trials on the pharmacological treatment of long COVID: A systematic review.长新冠的药物治疗临床试验：系统评价。
J Med Virol. 2023 Jan;95(1):e28289. doi: 10.1002/jmv.28289. Epub 2022 Nov 18.
10
The impact of platelets on pulmonary microcirculation throughout COVID-19 and its persistent activating factors.血小板对 COVID-19 全病程及持续激活因素肺微循环的影响。
Front Immunol. 2022 Sep 28;13:955654. doi: 10.3389/fimmu.2022.955654. eCollection 2022.
N Engl J Med. 2021 Jan 28;384(4):325-334. doi: 10.1056/NEJMoa2008470. Epub 2021 Jan 13.
4
Evidence of Pulmonary Hypertension after SARS-CoV-2 Infection in Subjects without Previous Significant Cardiovascular Pathology.既往无明显心血管疾病史的新型冠状病毒2感染患者发生肺动脉高压的证据
J Clin Med. 2021 Jan 7;10(2):199. doi: 10.3390/jcm10020199.
5
Recurrent SARS-CoV-2 infection resulting in acute respiratory distress syndrome and development of pulmonary hypertension: A case report.复发性严重急性呼吸综合征冠状病毒2感染导致急性呼吸窘迫综合征和肺动脉高压：一例报告。
Respir Med Case Rep. 2021;33:101314. doi: 10.1016/j.rmcr.2020.101314. Epub 2020 Dec 5.
6
SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells.SARS-CoV-2 刺突蛋白介导的肺血管细胞中的细胞信号转导。
Vascul Pharmacol. 2021 Apr;137:106823. doi: 10.1016/j.vph.2020.106823. Epub 2020 Nov 21.
7
Antifibrotics in COVID-19 Lung Disease: Let Us Stay Focused.新冠肺病中的抗纤维化药物：让我们专注于此。
Front Med (Lausanne). 2020 Sep 9;7:539. doi: 10.3389/fmed.2020.00539. eCollection 2020.
8
Respiratory follow-up of patients with COVID-19 pneumonia.COVID-19 肺炎患者的呼吸随访。
Thorax. 2020 Nov;75(11):1009-1016. doi: 10.1136/thoraxjnl-2020-215314. Epub 2020 Aug 24.
9
Post-COVID-19 pneumonia pulmonary fibrosis.新型冠状病毒肺炎后肺纤维化
QJM. 2020 Nov 1;113(11):837-838. doi: 10.1093/qjmed/hcaa255.
10
Pulmonary fibrosis in the aftermath of the COVID-19 era (Review).新冠疫情时代后的肺纤维化（综述）
Exp Ther Med. 2020 Sep;20(3):2557-2560. doi: 10.3892/etm.2020.8980. Epub 2020 Jul 9.